tivantinib
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for tivantinib, covering 2013-02-08 to 2022-09-09. Get the full timeline:
Most recent: Clinical Trial Update: Study of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects [Phase 2]